The China Antibiotic Resistance Market is increasingly characterized by a dual dynamic: rapid growth in domestic innovation and strategic engagement by multinational pharmaceutical companies. As China confronts its severe burden of drug-resistant infections, both local and international players are investing in the development, approval, and commercialization of new antibiotics, diagnostics,...
